Opaleye Management’s Context Therapeutics CNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,108,357
Closed -$1.53M 53
2024
Q1
$1.53M Buy
1,108,357
+133,357
+14% +$184K 0.33% 42
2023
Q4
$1.1M Buy
+975,000
New +$1.1M 0.29% 43